ropinirole has been researched along with rotenone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Du, Y; Le, W; Li, L; Li, X; Ming, M; Yang, D; Zhang, X | 1 |
| Barcia, E; Boeva, L; Fernandez-Carballido, A; Garcia-García, L; Negro, S; Slowing, K | 1 |
| Raj, K; Sharma, S; Singh, S | 1 |
3 other study(ies) available for ropinirole and rotenone
| Article | Year |
|---|---|
D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways.
Topics: Apoptosis; Caspase 3; Caspase 9; Caspase Inhibitors; Cell Line; Cytoprotection; Dopamine; Enzyme Activation; Humans; Indoles; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-jun; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Rotenone | 2008 |
Efficacy of Ropinirole-Loaded PLGA Microspheres for the Reversion of Rotenone- Induced Parkinsonism.
Topics: Animals; Antiparkinson Agents; Cell Line, Tumor; Cell Survival; Humans; Indoles; Insecticides; Lactic Acid; Male; Microspheres; Parkinsonian Disorders; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Rotenone; Treatment Outcome | 2017 |
Neuroprotective Effect of Quercetin in Combination with Piperine Against Rotenone- and Iron Supplement-Induced Parkinson's Disease in Experimental Rats.
Topics: Alkaloids; Benzodioxoles; Corpus Striatum; Dietary Supplements; Drug Synergism; Electron Transport Complex I; Electron Transport Complex IV; Glutathione; Indoles; Interleukin-1beta; Interleukin-6; Iron; Lipid Peroxidation; Neuroprotective Agents; Neurotransmitter Agents; Nitrites; Parkinson Disease, Secondary; Piperidines; Polyunsaturated Alkamides; Quercetin; Rotenone; Tumor Necrosis Factor-alpha | 2020 |